Mauricio Camus

Santiago, RM, Chile

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

ThyroidPrint: Thyroid Genetic Classifier Long-Term Follow-Up of Benign Called Lesions.

ThyroidPrint: Thyroid Genetic Classifier Long-Term Follow-Up of Benign Called Lesions.

Journal: Clinical endocrinology

Published: December 17, 2025

Clinical and biomarker predictors of early and late recurrence in hormone receptor-positive breast cancer.

Clinical and biomarker predictors of early and late recurrence in hormone receptor-positive breast cancer.

Journal: BMC cancer

Published: December 09, 2025

Pathologic complete response and survival in early-stage HER2-positive breast cancer patients treated with or without anthracyclines.

Pathologic complete response and survival in early-stage HER2-positive breast cancer patients treated with or without anthracyclines.

Journal: Ecancermedicalscience

Published: October 13, 2025

Suboptimal use of ovarian function suppression in very young women with early breast cancer: a real-world data study.

Suboptimal use of ovarian function suppression in very young women with early breast cancer: a real-world data study.

Journal: Breast cancer research and treatment

Published: July 05, 2023

Access disparities and underutilization of germline genetic testing in Chilean breast cancer patients.

Access disparities and underutilization of germline genetic testing in Chilean breast cancer patients.

Journal: Breast cancer research and treatment

Published: January 16, 2023

ThyroidPrint®: clinical utility for indeterminate thyroid cytology.

ThyroidPrint®: clinical utility for indeterminate thyroid cytology.

Journal: Endocrine-related cancer

Published: December 25, 2022

Clinical characteristics, risk factors, and outcomes in Chilean triple negative breast cancer patients: a real-world study.

Clinical characteristics, risk factors, and outcomes in Chilean triple negative breast cancer patients: a real-world study.

Journal: Breast cancer research and treatment

Published: August 16, 2022

Contrast-enhanced mammography predicts pathological response after neoadjuvant chemotherapy in locally advanced breast cancer.

Contrast-enhanced mammography predicts pathological response after neoadjuvant chemotherapy in locally advanced breast cancer.

Journal: Ecancermedicalscience

Published: October 23, 2021

Screen-detected breast cancer is associated with better prognosis and survival compared to self-detected/symptomatic cases in a Chilean cohort of female patients.

Screen-detected breast cancer is associated with better prognosis and survival compared to self-detected/symptomatic cases in a Chilean cohort of female patients.

Journal: Breast cancer research and treatment

Published: March 12, 2021

Pathological complete response to neoadjuvant chemotherapy, but not the addition of carboplatin, is associated with improved survival in Chilean triple negative breast cancer patients: a report of real world data.

Pathological complete response to neoadjuvant chemotherapy, but not the addition of carboplatin, is associated with improved survival in Chilean triple negative breast cancer patients: a report of real world data.

Journal: Ecancermedicalscience

Published: September 08, 2020

Management of non-invasive tumours, benign tumours and breast cancer during the COVID-19 pandemic: recommendations based on a Latin American survey.

Management of non-invasive tumours, benign tumours and breast cancer during the COVID-19 pandemic: recommendations based on a Latin American survey.

Journal: Ecancermedicalscience

Published: May 26, 2020

Survival rates of advanced estrogen-receptor positive breast cancer. Analysis of 211 cases.

Survival rates of advanced estrogen-receptor positive breast cancer. Analysis of 211 cases.

Journal: Revista medica de Chile

Published: May 13, 2020

Showing 1-12 of 31

Last Updated: 09/26/2026